BRUKER CORPORATION Proceeds from (Repayments of) Debt
BRUKER CORPORATION (BRKR) reported Proceeds from (Repayments of) Debt of -$6.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2024-02-29
- BRUKER CORPORATION proceeds from (repayments of) debt for fiscal 2023 was -$6.50M, a 2266.67% decline from fiscal 2022.
- BRUKER CORPORATION proceeds from (repayments of) debt for fiscal 2022 was $300.00K, a 99.94% decline from fiscal 2021.
- BRUKER CORPORATION proceeds from (repayments of) debt for fiscal 2021 was $490.50M.
| Period end | Proceeds from (Repayments of) Debt 12 month |
|---|---|
| 2023-12-31 | -$6.50M 10-K · filed 2024-02-29 |
| 2022-12-31 | $300.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $490.50M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |